243 related articles for article (PubMed ID: 29477943)
1. The use of emergency apheresis in the management of plasma cell disorders.
Kalayoglu-Besisik S
Transfus Apher Sci; 2018 Feb; 57(1):35-39. PubMed ID: 29477943
[TBL] [Abstract][Full Text] [Related]
2. Hyperviscosity in plasma cell dyscrasias.
Kwaan HC
Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of therapeutic procedure for Waldenström's macroglobulinemia with hyperviscosity syndrome.
Ito K; Kawasaki T; Hirano K; Sekiguchi N
Ther Apher Dial; 2024 Jun; 28(3):417-423. PubMed ID: 38069574
[TBL] [Abstract][Full Text] [Related]
4. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
Menke MN; Feke GT; McMeel JW; Treon SP
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
[TBL] [Abstract][Full Text] [Related]
5. Hyperviscosity-related retinopathy and serous macular detachment in Waldenström's macroglobulinemia: A mortal case in 5 years.
Lai CC; Chang CH
Eur J Ophthalmol; 2022 Jul; 32(4):NP109-NP114. PubMed ID: 33719618
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia.
Menke MN; Feke GT; McMeel JW; Treon SP
Clin Lymphoma Myeloma; 2009 Mar; 9(1):100-3. PubMed ID: 19362987
[TBL] [Abstract][Full Text] [Related]
7. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
[TBL] [Abstract][Full Text] [Related]
8. Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenström's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.
Siami GA; Siami FS
Ther Apher; 1999 Feb; 3(1):8-19. PubMed ID: 10079800
[TBL] [Abstract][Full Text] [Related]
9. Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
Stone MJ
Clin Lymphoma Myeloma; 2009 Mar; 9(1):97-9. PubMed ID: 19362986
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab in macular serous detachments associated with Waldenstrom's macroglobulinemia.
Kapoor KG; Wagner MS
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):95-7. PubMed ID: 25559519
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic apheresis for the renal complications of multiple myeloma and the dysglobulinemias.
Kaplan AA
Ther Apher; 2001 Jun; 5(3):171-5. PubMed ID: 11467752
[TBL] [Abstract][Full Text] [Related]
12. Histidine based adsorbents for selective removal of monoclonal immunoglobulin IgM antibodies from Waldenstrom's macroglobulinemia patient sera: a preliminary study.
Srour M; Kassab I; Matta H; Elkak A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():1-5. PubMed ID: 23811496
[TBL] [Abstract][Full Text] [Related]
13. Role of plasmapheresis in Waldenström's macroglobulinemia.
Stone MJ; Bogen SA
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):238-40. PubMed ID: 23522642
[TBL] [Abstract][Full Text] [Related]
14. Hyperviscosity syndrome in plasma cell dyscrasias.
Mehta J; Singhal S
Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
[TBL] [Abstract][Full Text] [Related]
15. The plasma cell dyscrasias: diverse presentations, pathophysiology, and management.
Eichner ER
Postgrad Med; 1980 Jun; 67(6):44-9, 53-4, 57-8 passim. PubMed ID: 6769101
[TBL] [Abstract][Full Text] [Related]
16. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
[TBL] [Abstract][Full Text] [Related]
17. Bilateral, persistent serous macular detachments with Waldenström's macroglobulinemia.
Pilon AF; Rhee PS; Messner LV
Optom Vis Sci; 2005 Jul; 82(7):573-8. PubMed ID: 16044069
[TBL] [Abstract][Full Text] [Related]
18. Mid-peripheral hemorrhages secondary to Waldenström's macroglobulinemia.
Goen TM; Terry JE
J Am Optom Assoc; 1986 Feb; 57(2):109-12. PubMed ID: 3081619
[TBL] [Abstract][Full Text] [Related]
19. Massive hollow fiber clotting: a distinct problem in treatment of cryoglobulinemia by membrane plasmapheresis.
Lai KN; Cheng SC; Vallance-Owen J
Artif Organs; 1987 Jun; 11(3):259-64. PubMed ID: 3113406
[TBL] [Abstract][Full Text] [Related]
20. Bilateral central retinal vein occlusion in Waldenström's macroglobulinemia.
Avashia JH; Fath DF
J Am Optom Assoc; 1989 Sep; 60(9):657-8. PubMed ID: 2507620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]